Berman Capital Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$5K Buy
60
+27
+82% +$2.44K ﹤0.01% 1449
2021
Q2
$2K Buy
33
+22
+200% +$1.86K ﹤0.01% 1657
2021
Q1
$0 Hold
11
﹤0.01% 1951
2020
Q4
$0 Hold
11
﹤0.01% 1873
2020
Q3
$0 Sell
11
-19
-63% -$1.13K ﹤0.01% 1824
2020
Q2
$1K Buy
30
+19
+173% +$1.02K ﹤0.01% 1546
2020
Q1
$0 Hold
11
﹤0.01% 1727
2019
Q4
$0 Hold
11
﹤0.01% 1578
2019
Q3
$0 Hold
11
﹤0.01% 1620
2019
Q2
$0 Hold
11
﹤0.01% 1613
2019
Q1
$0 Hold
11
﹤0.01% 1512
2018
Q4
$0 Buy
+11
New +$511 ﹤0.01% 1289

Other funds holding SYNH

Berman Capital Advisors's SYNH Position: Q3 2021 in Review

Berman Capital Advisors increased its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 82% in Q3 2021, buying an estimated $2.44K and bringing the position to 60 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1449.

Berman Capital Advisors first reported a position in SYNH in Q4 2018 and has held it in 12 quarters since. 355 funds tracked by Wall St. Rank hold SYNH as of Q3 2021.

  • Berman Capital Advisors held 60 shares of Syneos Health, Inc. Class A Common Stock worth $5K as of Q3 2021.
  • Berman Capital Advisors bought 27 Syneos Health, Inc. Class A Common Stock shares in Q3 2021, an estimated $2.44K.
  • Syneos Health, Inc. Class A Common Stock made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1449 holding.
  • Berman Capital Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and has held it in 12 quarters since.
  • 355 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.